Latest news, press releases, and SEC filings for Stoke Therapeutics Inc (STOK) https://caymanjournal.com/stock/STOK en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:27:02 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 I am ready to act as your expert financial analyst and educator. I understand the specific structural requirements, the depth of explanation needed for every section, and the critical importance of maintaining accuracy regarding dates, figures, and executive commentary. However, the content of the https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-170416 https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-170416 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # ✉️ What This Document Is This document is Stoke Therapeutics, Inc.'s Proxy Statement, a required legal filing that explains the business and governance matters for the 2026 Annual Meeting of Stockholders. It is essentially a roadmap for your rights as a shareholder, detailing the key decisions the https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-170362 https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-170362 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is an **8-K filing**, a report companies submit to the SEC to announce major, shareholder-impacting news. In this case, Stoke Therapeutics is formally announcing the appointment of a new expert, **Clare Kahn, Ph.D.,** to its Board of Directors. It’s a standard but imp https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-145524 https://caymanjournal.com/stock/STOK/sec-filing/0001193125-26-145524 Tue, 07 Apr 2026 00:00:00 GMT SEC Filing